| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0004 |